metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-120 ANTHROPOMETRIC AND METABOLIC PROFILE IN NON-ALCOHOLIC FATTY LIVER DISEASE
Información de la revista
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Acceso a texto completo
P-120 ANTHROPOMETRIC AND METABOLIC PROFILE IN NON-ALCOHOLIC FATTY LIVER DISEASE
Visitas
416
Lara Ramos de Prado, Mariana Sophia Santos Almeida, Ana Ester Amorim de Paula, Maria Auxiliadora Nogueira Saad, Rosa Leonora Salerno Soares, Priscila Pollo Flores, Débora Vieira Soares
Hepatic Department, Federal University of Fluminense, Fluminense, Brazil
Este artículo ha recibido
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 28. Núm S1

Abstracts of the 2022 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease, with a worldwide prevalence of 25%. This disease is characterized by the accumulation of fat in the hepatocyte in the absence of secondary causes such as excessive alcohol consumption, drugs, or hereditary causes and can progress to steatohepatitis with or without fibrosis, cirrhosis and even hepatocellular carcinoma. The association between NAFLD and obesity, type 2 diabetes mellitus and metabolic syndrome is well established. It is estimated that approximately 76% of individuals with obesity, mainly visceral obesity, have NAFLD. In addition, previous studies have shown that simple anthropometric measures of body fat assessment, such as body mass index (BMI), neck circumference (NC), waist circumference (WC) and waist-hip ratio (WHR), are predictors of NAFLD. This study aimed to assess the prevalence of NAFLD in obese individuals and the role of anthropometric measurements that estimate visceral fat as a predictor of NAFLD.

Materials and Methods: Cross-sectional study. The study sample is a convenience sample

adults over 18 years of age, followed up at the outpatient clinics of Internal Medicine and Endocrinology of the Hospital University Antonio Pedro and at risk of NAFLD (pre-diabetes, type 2 diabetes mellitus, metabolic syndrome and/or obesity). To participate in the study, it was necessary to sign an informed consent form and clinical and anthropometric assessment, metabolic profile and liver ultrasound, elastography and electrical bioimpedance tests were performed.

Results

The evaluation was performed on 95 patients. There is a predominance of females in relation to males (81% vs. 18.9%, respectively) and a higher prevalence of alcoholism and diabetes in males (50% and 66.6%) when compared to females (18.1% and 48%). Furthermore, there is a high prevalence of physical inactivity, smoking, hypertension and dyslipidemia in both sexes. The prevalence of hepatic steatosis in 91.30% of women and 63.6% of men who underwent abdominal ultrasounds is another important observation. Anthropometric measurements such as NC, WC, and WHR are high in both sexes. Circumferences, in cm, of the neck and waist were greater in males (medians 42 cm and 106.9 cm) compared to females (medians 36.1 cm and 105 cm).

Conclusions

To date, a high prevalence of patients with visceral obesity, hepatic steatosis and metabolic diseases has been observed. Regarding the anthropometric measures of visceral obesity, they are high in both sexes, proving to be an important risk factor for NAFLD. The study is ongoing and further statistical analyzes will be performed to identify the association of hepatic steatosis with cardiometabolic diseases.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2021.100392
No mostrar más